Analysis of clinical laboratory test results of 4 imported COVID-19 patients infected with the SARS-CoV-2 Delta variant

ZHOU Xue; CHEN Xiaolong; WU Xiaomin; HUANG Xiner; LUO Wanrong; WANG Peng; WU Jiabing; HE Jun

doi:10.19837/j.cnki.ahyf.2023.05.020

PDF(969 KB)

Anhui Journal of Preventive Medicine ›› 2023, Vol. 29 ›› Issue (5) : 437-440. DOI: 10.19837/j.cnki.ahyf.2023.05.020

Preventive and Clinical Medicine

Analysis of clinical laboratory test results of 4 imported COVID-19 patients infected with the SARS-CoV-2 Delta variant

ZHOU Xue¹, CHEN Xiaolong², WU Xiaomin¹, HUANG Xiner³, LUO Wanrong¹, WANG Peng¹, WU Jiabing¹, HE Jun¹

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHOU Xue, CHEN Xiaolong, WU Xiaomin, HUANG Xiner, LUO Wanrong, WANG Peng, WU Jiabing, HE Jun. Analysis of clinical laboratory test results of 4 imported COVID-19 patients infected with the SARS-CoV-2 Delta variant[J]. Anhui Journal of Preventive Medicine. 2023, 29(5): 437-440 https://doi.org/10.19837/j.cnki.ahyf.2023.05.020

References

[1] 侯赛,卢思琦,孙袁芳,等.安徽省新型冠状病毒肺炎流行病学特征分析 [J].安徽预防医学杂志,2020,26(4):245-249.
[2] Shiehzadegan S,Alaghemand N,Fox M,et al.Analysis of the delta variant b.1.617.2 covid-19 [J].Clin Pract,2021,11(4):778-784.
[3] Badimon L,Pena E,Arderiu G,et al.C-reactive protein in atherothrombosis and angiogenesis [J].Front Immunol,2018,9:430.
[4] Pathak A,Agrawal A.Evolution of c-reactive protein [J].Front Immunol,2019,10:943.
[5] Ringel J,Ramlow A,Bock C,et al.Case report:c-reactive protein apheresis in a patient with COVID-19 and fulminant crp increase [J].Front Immunol,2021,12:708101.
[6] Tan Z,Li l,Ma Y,et al.Clinical significance of cys-c and hs-crp in coronary heart disease patients undergoing percutaneous coronary intervention [J].Braz J Cardiovasc Surg,2019,34(1):17-21.
[7] Kamath DY,Xavier D,Sigamani A,et al.High sensitivity c-reactive protein (hscrp) & cardiovascular disease:an indian perspective [J].Indian J Med Res,2015,142(3):261-268.
[8] Zhang L,Yan X,Fan Q,et al.D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19 [J].J Thromb Haemost,2020,18(6):1324-1329.
[9] Gao Z,Xu Y,Sun C,et al.A systematic review of asymptomatic infections with COVID-19 [J].J Microbiol Immunol Infect,2021,54(1):12-16.
[10] Yu HH,Qin C,Chen M,et al.D-dimer level is associated with the severity of COVID-19 [J].Thromb Res,2020,195:219-225.
[11] Wang X,Du B,Li J,et al.D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury:A case series [J].Medicine (Baltimore),2020,99(31):e21513.
[12] Fox SE,Lameira FS,Rinker EB,et al.Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19 [J].Ann Intern Med,2020,173(12):1025-1027.
[13] Anton-vazquez V,Byrne L,Anderson L,et al.COVID-19 cardiac injury and the use of colchicine [J].BMJ Case Rep,2021,14(2):e241047.